Factory Tour

    Chengdu Baishixing Technology Industry Co., Ltd. has established two major production bases in Pujian, Chengdu and Lanzhou. The core factory in Chengdu is located at No. 217, Industrial North Road, Heshan Street, Pujian County, Chengdu City, Sichuan Province, covering an area of over 18,000 square meters. It has professional production workshops and multiple production lines that meet GMP standards, mainly producing cell culture media raw materials, bioactive substances, amino acid derivatives, etc., with an annual output of over 1,000 tons. The Lanzhou base covers an area of 90 mu and is planned to build multiple cGMP standard production lines, focusing on the specialized production of protective amino acids. The company has a complete R&D and quality inspection system, holds the qualification of a high-tech enterprise, multiple ISO system certifications, and dozens of patent technologies. It offers over a hundred products in five major series, with many raw materials meeting the standards of European, American and Japanese pharmacopoeias and being exported overseas. Meanwhile, the company continuously upgrades the equipment and production lines in both factories, steadily expanding the production capacity layout related to pharmaceutical intermediates and biological raw materials.

    Chengdu Baishixin Technology Industry Co., Ltd. relies on its two standardized production bases in Chengdu and Lanzhou and its own R&D capabilities to provide professional ODM original formula research and development customization, OEM compliant contract manufacturing, and specialized fine chemical custom synthesis services. Its business covers core categories such as cell culture medium raw materials, various amino acids and derivatives, peptide products, and pharmaceutical intermediates. The company is equipped with GMP/cGMP high-standard production workshops and multiple specialized production lines. It possesses multiple patent technologies and a complete set of ISO quality system certifications. Its products comply with multiple national pharmacopoeia standards and can achieve full-process delivery from milligram-level pilot research to ton-level industrial production. The entire process strictly protects the client's intellectual property and technical secrets. It has rich international industry cooperation experience and can complete demand alignment, scheme design, sample confirmation, large-scale production, and issuance of compliant quality inspection reports in one step. It can provide stable, professional, and cost-effective customized contract manufacturing solutions for the biomedical and cell therapy fields.

    Chengdu Baishixin Technology Industry Co., Ltd. is a high-tech enterprise specializing in cell culture medium raw materials, amino acid derivatives, and pharmaceutical intermediates. It has a professional R&D team of about 30 people led by Dr. Shi Changqing and a provincial-level enterprise technology center. In 2015, it established an innovation studio and carried out industry-university-research cooperation with universities such as Wuhan University's School of Life Sciences. In recent years, the company has invested over 10 million yuan annually in research and development. It adheres to the gradient development strategy of "producing a batch, researching a batch, and preparing a batch". The enterprise has a total of 16 invention patents, 16 utility model patents, and 10 software copyrights. Among them, the production process of L-tyrosine disodium and bromine-free production process of whey acid fills the domestic gap. The product processes of protected amino acids and glycyl-L-tyrosine independently developed have advantages such as high raw material utilization, high purity, and environmental friendliness. Many technologies have reached international advanced levels and achieved import substitution. It can provide full-chain technical services from milligram-level laboratory research to ton-level industrial production, supporting the continuous iteration and innovation of more than 100 types of products. At the same time, it deeply participates in the formulation of industry standards such as "Construction Specifications for Pilot Plants of Chemical Drugs", providing high-quality core raw material solutions for the fields of biomedicine and cell therapy.